|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.195 CAD | 0.00% |
|
+14.71% | +5.41% |
| 03-15 | NeuPath Health Narrows Q4 Loss, Revenue Rises | MT |
| 03-15 | NeuPath Health Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
NeuPath Health Inc. reported earnings results for the full year ended December 31, 2022. For the full year, the company reported revenue was CAD 62.65 million compared to CAD 60.86 million a year ago. Net loss was CAD 4.17 million compared to CAD 3.23 million a year ago.
Basic loss per share from continuing operations was CAD 0.09 compared to CAD 0.07 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| +5.41% | 8.05M | |
| +17.73% | 83.46B | |
| -32.08% | 67.33B | |
| -3.24% | 25.66B | |
| +4.13% | 17.91B | |
| -13.68% | 16.54B | |
| +0.75% | 15.43B | |
| +74.92% | 13.46B | |
| +73.16% | 12.78B | |
| -2.02% | 12.33B |
NEUPATH HEALTH INC. 
